{
  "chapter": "Disorders-Substance Use And Addictive Disorders",
  "questions": [
    {
      "q_no": 1,
      "question": "A 30-year-old male patient presents to the emergency room after using opioids. He reports that shortly after taking the drug, he felt an intense euphoria, which was soon followed by a state of deep sedation. What is the term used to describe this state of alternating euphoria and sedation?",
      "options": {
        "A": "Mainlining",
        "B": "Skin popping",
        "C": "Chasing the dragon",
        "D": "Nodding off"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Nodding off Explanation: Nodding off refers to the state where initial euphoria is followed by sedation. It describes the characteristic behavior of opioid users when they experience a \"nod,\" indicating a state of drowsiness or semi-consciousness. Route of Administration of opioids: Oral Smoked Sublingual- eg. Buprenorphine Subcutaneous- Also known as skin popping. Used when no suitable blood vessels are available Intravenously- Gradually shifting from peripheral veins to larger veins or central veins is known as Mainlining . Snorted intranasally- Also known as \"Chasing the Dragon\". Clinical Features Produces a feeling of intense Euphoria (\"Rush\"), especially when taken Intravenously. Associated symptoms Feeling of warmth Dry mouth Heaviness of Extremities Facial Flushing Initial euphoria may be followed by a period of Sedation, known as Nodding Off . First time users may report Dysphoria, Nausea or vomiting.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 2,
      "question": "A 22-year-old male is brought to the emergency department after collapsing at a nightclub. On examination, he is disoriented, has a temperature of 39.5Â°C, and exhibits dilated pupils, tachycardia, and muscle rigidity. His friends report that he consumed a tablet given to him at the club. Which of the following drugs is the most likely cause of his symptoms?",
      "options": {
        "A": "Methylenedioxymethamphetamine",
        "B": "Cannabis",
        "C": "Psilocybin",
        "D": "Cathinone"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Methylenedioxymethamphetamine Explanation: The patient has likely consumed methylenedioxymethamphetamine (MDMA), which is an example of club drugs. Club drugs is a generic term for drugs associated with dance clubs and dance parties (rave parties). Also known as rave drugs . These include: Ecstasy (Methylenedioxymethamphetamine - MDMA). Flunitrazepam (Ropypnol/Roofies). Gamma HydroxyButyrate (GHB). Ketamine. LSD. Methamphetamine. Death Rape Drugs: Consumption of these drugs produce disorientation and sweating effects. After the effect goes away, the person may not remember what happened during that period. They include: K - Ketamine G - GHB F - Flunitrazepam Inhalant Drugs (Volatile substances/solvents): They are volatile hydrocarbons that vaporize into gaseous fumes at room temperature, inhaled through the nose or mouth. They are divided into four commercial classes: Solvents for glues and adhesives. Propellants (e.g., for aerosol paint sprays, hair sprays, and shaving cream). Thinners (e.g., for paint products and correction fluids). Fuels (e.g., gasoline, propane). Common methods of use include: Sniffing: Inhaled directly from the neck of the bottle. Huffing: Cloth dipped in solvent and held over nose and mouth. Bagging: Inhaled into a bag filled with solvent. Dusting: Spraying it directly over the nose or mouth. Serious adverse effects: Long-term use of these inhalers can cause irreversible liver disease or renal damage, muscle damage, peripheral neuropathy, and brain damage. Reference: Kaplan and Saddock Psychiatry, 12th Edition, Page 978",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 3,
      "question": "A 45-year-old male with a 20-year history of smoking presents to the outpatient clinic. He admits that he is aware of the health risks associated with smoking but feels that he is not ready to quit at this time. However, he has started reading articles about smoking cessation. According to the Transtheoretical Model of Change, which stage of behavior change is he most likely in?",
      "options": {
        "A": "Precontemplation",
        "B": "Contemplation",
        "C": "Preparation",
        "D": "Action"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Contemplation Explanation: Contemplation refers to an individual recognizing the problem and considering change , but who is not yet ready to take action based on the Transtheoretical Model of Change. The Transtheoretical Model of Change (also known as the Stages of Change Model) is a comprehensive model that describes an individual's journey through different stages of behavior change. Developed by Prochaska and DiClemente, this model is relevant in addiction, smoking cessation, and lifestyle changes. The model comprises five stages: Precontemplation The individual is not considering a change in behavior in the foreseeable future. They may be unaware or in denial about the need for change. In the scenario above, the patient is aware of the risks and is already exploring options, which rules out precontemplation. (Option A) Contemplation The individual recognizes the problem and is considering change , but is not yet ready to take action. The patient in this case is aware of the health risks and is actively seeking information, which aligns with contemplation. They are ambivalent about quitting, indicating they are considering, but not committed to, change. Preparation The individual is intending to take action in the near future (usually within the next 30 days) May have started taking small steps toward change. This patient has not yet reached this stage, as he is still ambivalent and has not committed to making concrete plans to quit smoking. (Option C) Action The individual has recently made changes (within the last 6 months) Actively working to maintain those changes. Since the patient has not taken any steps to quit, he is not in the action stage. (Option D) Maintenance The individual has sustained their behavior change for more than 6 months Working to prevent relapse.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 4,
      "question": "A 35-year-old man reports increasing financial troubles due to frequent horse racing bets. He's attempted to stop multiple times but fails, often betting more than intended. His job performance is suffering, and he's borrowed money from family under false pretenses. Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Impulse control disorder",
        "B": "Obsessive-compulsive disorder",
        "C": "Gambling disorder",
        "D": "Bipolar disorder"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Gambling Disorder Explanation: Gambling Disorder is an addictive disorder where patients exhibit a persistent and recurring pattern of gambling that leads to clinically significant impairment. Features include: Preoccupation with gambling, Needing to gamble with increasing amounts of money, Failed attempts to stop, Continued gambling despite severe consequences. This disorder has characteristics similar to substance use disorders, including tolerance, withdrawal symptoms (irritability when unable to gamble), and the use of gambling as a means of coping with stress I . Treatment for Gambling Disorder: Cognitive Behavioral Therapy (CBT) : Helps patients identify and change maladaptive thought patterns and behaviors related to gambling. Gamblers Anonymous (GA) : A peer-support group based on the 12-step model, offering mutual support for those trying to overcome their addiction. Pharmacotherapy : Medications such as SSRIs (e.g., fluoxetine) for underlying depression, mood stabilizers (e.g., lithium, lamotrigine) for mood regulation, and opioid antagonists (e.g., naltrexone) for reducing the urge to gamble. Family Therapy : Engaging family members in therapy helps to repair relationships and provides support for the gambler's recovery. Hospitalization : In severe cases, temporary hospitalization may be required to remove patients from their gambling environment I . Other Addictive Behavioural disorder: Internet Gaming Disorder, as defined in the DSM-5, refers to excessive and compulsive participation in online gaming that significantly impairs personal, social, and occupational functioning. Unlike Gambling Disorder, it typically does not involve financial, legal, or relational harms. The disorder is characterized by persistent or recurring gaming behavior (whether digital or video games), either online (via the internet) or offline, which manifests through: Impaired control over gaming : Difficulty regulating the onset, duration, or stopping of gameplay. Prioritization of gaming over daily activities : Gaming takes precedence over essential responsibilities. Continuation of gaming despite negative consequences : Gaming persists even when it leads to adverse effects on life. This behavior results in notable impairment in overall functioning. Impulse control disorder (Option A): While gambling disorder was previously classified under impulse control disorders, it's now considered a behavioral addiction in the DSM-5. The term \"impulse control disorder\" is very broad and doesn't specifically capture the addiction-like nature of problematic gambling behavior. Obsessive-compulsive disorder (OCD) (Option B): Although there can be obsessive thoughts about gambling, OCD is characterized by",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 5,
      "question": "A 45-year-old man presents with mood changes, increased anxiety, and difficulty sleeping, which have progressively worsened over the past week. He has a history of heavy smoking (30 cigarettes/day for 20 years) and quit smoking abruptly 8 days ago due to concerns about his health. Despite wanting to stay off cigarettes, he reports intense cravings, inability to focus, and feeling \"on edge\" all the time. He has attempted nicotine replacement therapy (NRT) in the past without success. Which of the following medications is most likely to help alleviate both his nicotine cravings and mood symptoms without causing significant weight gain?",
      "options": {
        "A": "Varenicline",
        "B": "Bupropion",
        "C": "Nicotine patch",
        "D": "Nortriptyline"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Bupropion Explanation: Withdrawal Symptoms of nicotine: When nicotine is abruptly stopped, individuals experience withdrawal symptoms such as irritability, anxiety, depression, difficulty concentrating, increased appetite, and insomnia. These symptoms are due to a sudden drop in dopamine and other neurotransmitters. Develops within 2 hours of smoking the last cigarette. The peak is achieved in 24-48 hours. Withdrawal Symptoms- lasts up to 2-3 weeks. Nicotine Action and Dependence Pathway: Nicotine ingestion â Nicotine activates nicotinic acetylcholine receptors (nAChRs) â nAChRs stimulation in the brain â Activation of the Ventral Tegmental Area (VTA) â Release of dopamine in the Nucleus Accumbens â Rewarding & reinforcing effects â Chronic stimulation of nAChRs â Development of dependence Treatment: The 5 A's Approach: 1. Ask Record tobacco use status at every visit. 2. Advise Strongly encourage quitting in a personalized way. 3. Assess Determine if the patient is willing to quit at this time. 4. Assist Use counseling and pharmacotherapy to help in quitting. 5. Arrange Schedule follow-up within the first week after quitting. Psychosocial Therapies: Behavioral Therapy : Focus on skills training, relapse prevention, and stimulus control. Aversive Therapy : Smoking until nausea associates the behavior with unpleasant sensations. Hypnosis : Can help by implanting suggestions that discourage smoking. Pharmacological Therapies: Medication Dosage Mechanism of Action Adverse Effects Additional Info Nicotine Replacement Therapies (NRTs) Nicotine Replacement (NRT) Patch (OTC) Typically 6-12 weeks of maintenance, follow manufacturer guidelines Delivers nicotine in controlled doses to reduce withdrawal symptoms and cravings. Skin irritation (patch), insomnia (24-hour patch). Provides nicotine without harmful tobacco toxins. Combine well with gum for extra support. Nicotine Gum/Lozenge Oral (OTC) 2 mg for <25 cigarettes/day, 4 mg for >25 cigarettes/day Replaces nicotine to ease withdrawal symptoms; absorbed via buccal mucosa. Sore jaw (gum), heartburn, nausea, hiccups, headache. Avoid acidic drinks during use as they",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 6,
      "question": "A 32-year-old male, with a history of frequent cocaine use for the past 6 years, presents with intense fatigue, excessive sleep, increased appetite, and feelings of anhedonia. He states that he stopped using cocaine abruptly 3 days ago. On further questioning, he reports that over the past few months, his cocaine use had escalated to daily use. He also mentions experiencing intense cravings for cocaine and irritability but denies hallucinations or delusions. On physical examination, the patient is lethargic, and his vital signs are stable. Which of the following is the most appropriate management strategy for this patient at this stage?",
      "options": {
        "A": "Immediate initiation of dopamine agonist therapy",
        "B": "Long-term use of antipsychotic medications",
        "C": "Supportive care and monitoring",
        "D": "Administration of benzodiazepines to prevent withdrawal seizures"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Supportive care and monitoring Explanation: This patient is exhibiting classic signs of cocaine withdrawal , which include fatigue, hypersomnia, increased appetite, dysphoria (such as anhedonia), and irritability. Cocaine withdrawal is not life-threatening and typically does not require pharmacologic treatment beyond symptomatic care. The management at this stage involves supportive care with close monitoring. Cocaine Withdrawal: Cocaine withdrawal symptoms are predominantly psychological and include intense cravings, anhedonia, dysphoria, irritability, hypersomnia, and increased appetite. Unlike alcohol or benzodiazepine withdrawal, it is not associated with physical complications like seizures or delirium tremens. The acute withdrawal phase (\" crash \") lasts for a few days, followed by a more prolonged phase with mood disturbances and drug cravings. Cocaine-Induced Psychotic Disorder: Characterized by paranoid delusions and hallucinations . Affects up to 50% of stimulant users . Types of Hallucinations: Auditory hallucinations are common. Visual and tactile hallucinations are less common but may occur. Cocaine can cause formication/ Cocaine bugs (sensation of bugs crawling under the skin). Symptoms depend on dose , duration of use , and individual sensitivity to stimulants. More frequent in users of intravenous cocaine or crack cocaine . Psychotic symptoms are seen more in men than in women. Treatment: The preferred treatment is short-term use of antipsychotics like haloperidol , especially for amphetamine-induced psychosis. Treatment for Cocaine Withdrawal: Supportive care : The mainstay of treatment includes managing symptoms such as fatigue and depression, encouraging sleep, and monitoring for suicidal ideation. Behavioral interventions : Cognitive-behavioral therapy (CBT) and psychological support are considered the most effective long-term treatments for cocaine addiction for preventing relapse. Immediate initiation of dopamine agonist therapy (Option A): Dopamine agonist therapy is not part of the recommended management for cocaine withdrawal. Long-term use",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 7,
      "question": "A 25-year-old man is brought by his friends after collapsing at a party. He had been using a substance throughout the night that reportedly gave him a surge of euphoria and energy, but soon after, he started experiencing palpitations, intense sweating, and chest pain. On examination, his heart rate is 140 bpm, and his blood pressure is 190/120 mm Hg. The patient appears agitated and confused. His pupils are dilated. An ECG shows signs of acute myocardial ischemia. Which of the following best explains the mechanism of action of the substance this patient likely consumed?",
      "options": {
        "A": "Increased release of gamma-aminobutyric acid (GABA)",
        "B": "Inhibition of norepinephrine reuptake",
        "C": "Enhanced serotonin degradation",
        "D": "Stimulation of opioid receptors"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Inhibition of norepinephrine reuptake Explanation: This patientâs symptoms (euphoria, dilated pupils, palpitations, hypertension, agitation, and signs of myocardial ischemia) are classic for cocaine intoxication , a powerful stimulant drug. Cocaine works primarily by inhibiting the reuptake of norepinephrine, dopamine, and serotonin in the brain, resulting in increased levels of these neurotransmitters in the synaptic cleft. This leads to the intense euphoria and stimulation observed in users, along with sympathomimetic effects such as tachycardia and hypertension. Cocaine: Derived from the leaves of the coca plant ( Erythroxylum coca ). Mechanism of Action: Cocaine Enters Synapse â Inhibits Presynaptic Transporters â Blocks Reuptake of Neurotransmitters (Norepinephrine (NE), Dopamine (DA), Serotonin (5-HT)) â Increased Concentration of NE, DA, and 5-HT in Synapse â Enhanced Neurotransmitter Effect at Postsynaptic Receptors Methods of Use: Snorting: Cocaine is finely chopped and inhaled through the nose. Least dangerous compared to other methods, but still harmful. Subcutaneous or Intravenous Injection: Cocaine is dissolved and injected under the skin or directly into the bloodstream. Highly dangerous, and associated with a high risk of overdose, cardiac abnormalities, and cerebrovascular diseases. Smoking (Freebasing or Crack Cocaine): Freebasing: Street cocaine is mixed with chemically extracted pure cocaine alkaloid to increase its effect, and then smoked. Crack Cocaine: A potent, freebase form of cocaine sold as \"rocks\" that are smoked. One of the most dangerous methods, often leading to intense cravings and addiction. Associated with extreme behavioral changes and health risks like cardiac problems and death. Combination of Cocaine and Heroin is called Speed Balls. Oral Use: Cocaine can be ingested orally, but this method is rare and considered ineffective by users. Intoxication Effects: Euphoria, increased energy, hyperactivity, enhanced alertness, agitation, tachycardia, hypertension, dilated pupils, and risk of acute cardiovascular events. Adverse Effects: Hypertension Tachycardia Myocardial ischemia/infarction Seizures Arrhythmias Hyperthermia. Chronic use can lead to anxiety, paranoia, and hallucinations. Increased release of GABA (Option A): This would lead to sedative effects, which are the opposite of the symptoms described in the",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 8,
      "question": "A 22-year-old college student is brought to the emergency department by his friends after exhibiting bizarre behavior at a party. He appears disoriented, has dilated pupils, and reports seeing vivid colors and patterns. His vital signs show tachycardia and mild hypertension. Which of the following is the most likely cause of his symptoms?",
      "options": {
        "A": "Phencyclidine (PCP) intoxication",
        "B": "Lysergic acid diethylamide (LSD) intoxication",
        "C": "Methamphetamine overdose",
        "D": "Cannabis-induced psychosis"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Lysergic acid diethylamide (LSD) intoxication Explanation: The patient's symptoms, including disorientation, dilated pupils, visual hallucinations (seeing vivid colors and patterns), tachycardia, and mild hypertension, are consistent with LSD intoxication. Lysergic acid diethylamide (LSD) Chemical nature Synthetic base derived from lysergic acid nucleus from ergot alkaloids Common forms Tablets, liquid, blotter paper (\"blotter acid\") Potency 100 Âµg of LSD â 10-15 mg of psilocybin â 300-400 mg of mescaline Onset and duration Onset within an hour, peaks in 2-4 hours, lasts 8-12 hours Common physiologic symptoms â¢ Dilated pupils â¢ Increased deep tendon motor reflexes â¢ Muscle tension â¢ Mild motor incoordination â¢ Ataxia Occasional physiologic symptoms â¢ Increased heart rate â¢ Increased respiration â¢ Hypertension â¢ Nausea â¢ Decreased appetite â¢ Salivation â¢ Sweating â¢ Blurred vision Psychological effects â¢ Visual and perceptual changes â¢ Altered sense of time â¢ Mood changes â¢ Possible anxiety or paranoia â¢ Possible feelings of insight or creativity Associated phenomenon â¢ Flashback phenomenon â¢ Badtrip (also seen with cannabis) â¢ Reflex hallucination/ morbid synesthesia (may occur with other hallucinogens) Tolerance Develops quickly (2-3 days of repeated use), lost after 4-6 days of abstinence Potential risks â¢ Accidents due to impaired judgment â¢ Rarely, a syndrome similar to neuroleptic malignant syndrome â¢ Possible triggering of anxiety or depression in some users Date Rape Drugs: Substances used to incapacitate victims, facilitating sexual assault by impairing memory and consciousness. Common drugs include: Flunitrazepam (Rohypnol) : A benzodiazepine causing deep sedation, muscle relaxation, and amnesia. Known for inducing memory loss, it is undetected due to its rapid action and dissociative effects. Gamma-Hydroxybutyric Acid (GHB) : A CNS depressant causing euphoria, sedation, and amnesia. High doses lead to unconsciousness and respiratory depression. It is colorless and odorless, making it easy to mix into drinks. Gamma-Butyrolactone (GBL): A prodrug of GHB, converted in the body to produce similar sedative and amnesic effects. Ketamine: A dissociative anesthetic causing detachment, memory loss, and unconsciousness at higher doses. While PCP can cause disorientation and altered perceptions, it typically presents with more severe symptoms such as aggressive behavior, nystagmus, and a more pronounced hypertension. The vivid visual hallucinations described are more characteristic of LSD ( Option A) Methamphetamine intoxication would",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 9,
      "question": "A 28-year-old man is brought to the emergency department by police after exhibiting bizarre behavior in public. He appears disoriented, has nystagmus, and is expressing paranoid thoughts. His vital signs show hypertension and hyperthermia. Upon questioning, he admits to using a substance he calls \"angel dust.\" Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Alcohol intoxication",
        "B": "Opioid overdose",
        "C": "Phencyclidine intoxication",
        "D": "Ketamine intoxication"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Phencyclidine intoxication Explanation: The patient's symptoms, including disorientation, nystagmus, paranoid thoughts, hypertension, and hyperthermia, are consistent with Phencyclidine (PCP) intoxication. Additionally, \"angel dust\" is a common street name for PCP. Phencyclidine & Ketamine Origin Dissociative anesthetic agents; ketamine is closely related to PCP Forms Phencyclidine- Crystalline powder/paste added to cannabis or parsley-containing cigarettes Ketamine- Powder or solution for intranasal, oral, inhalational, or intravenous use Mechanism Works at the NMDA receptor (as antagonist), causing hallucinations and dissociated state Physical effects Cardiovascular stimulation No respiratory depression Hypertension Tachycardia Increased salivation Nystagmus Psychological effects Altered sense of body and reality Dissociative effects Onset and duration Phencyclidine- Effects occur in about 5 minutes, plateau in 30 minutes when smoked Ketamine- Onset within seconds when used intravenously, analgesia lasting 40 minutes, dissociative effects for hours Metabolism N-demethylated by liver microsomal cytochrome P450 (CYP), especially CYP3A4, into norketamine Detection Phencyclidine- Detectable in urine & blood Ketamine- Detectable in urine, with half-lives of 3, 4, and 7 hours for ketamine, norketamine, and dehydronorketamine respectively Recent developments in usage Phencyclidine- Not used clinically Ketamine- Growing use in ketamine infusion clinics for depression treatment, FDA approval of esketamine nasal spray for treatment-resistant depression Drug Street Names Cocaine Coke, Blow, Snow, Nose candy Heroin Smack, H, Dope, Junk, Brown Methamphetamine Meth, Ice, Crystal, Tina MDMA (Ecstasy) Molly, E, XTC, Adam Marijuana Weed, Pot, Mary Jane, Bud LSD Acid, Lucy, Tabs, Trips Prescription Opioids Oxy, Hillbilly Heroin, Percs, Vikes Benzodiazepines Benzo, Xanax, Bars, Sleepers Synthetic cannabinoids Spice, K2, Black Mamba While alcohol intoxication can cause disorientation and behavioral changes, it doesn't cause nystagmus, hypertension, or hyperthermia. The paranoid thoughts and the use of the term \"angel dust\" are not characteristic of alcohol intoxication ( Option A) Signs of opioid overdose include respiratory depression, pinpoint pupils, and decreased level of consciousness or coma. The hypertension, hyperthermia, and paranoid thoughts described in the case are not consistent with opioid overdose. Moreover, the term \"angel dust\" is not associated with opioids ( Option B) While ketamine is also a dissociative drug and can cause some similar",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 10,
      "question": "A 23-year-old college student presents to the university health center with complaints of anxiety, paranoid thoughts, and difficulty concentrating. He reports daily cannabis use for the past year. Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Cannabis-induced psychotic disorder",
        "B": "Cannabis-induced anxiety disorder",
        "C": "Amotivational syndrome",
        "D": "Cannabis use disorder"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Cannabis-induced anxiety disorder Explanation: The patient's symptoms of anxiety and paranoid thoughts during active cannabis use are most consistent with Cannabis-induced anxiety disorder . Cannabis-induced anxiety disorder is common during acute intoxication and is characterized by short-lived anxiety states often provoked by paranoid thoughts Disorder Key Features Cannabis Use Disorder (Option D) â¢ Prolonged daily use of cannabis for weeks to months â¢ Risk increases with earlier age of first use and longer duration of use â¢ Affects approximately 1 in 10 cannabis users Cannabis-Induced Psychotic Disorder (Option A) â¢ Rare occurrence of genuine psychotic process â¢ Transient paranoid ideation is more common â¢ \"Florid psychosis\" or \"hemp insanity\" in high potency cannabis use â¢ Often associated with preexisting personality disorders Cannabis-Induced Anxiety Disorder â¢ Common during acute intoxication â¢ Short-lived anxiety states often provoked by paranoid thoughts â¢ May induce panic attacks â¢ More common in inexperienced users Cognitive Impairment â¢ Long-term use may produce subtle cognitive impairments â¢ Affects memory, attention, and organization â¢ More pronounced with longer periods of heavy use â¢ Unclear if impairments resolve after extended abstinence Amotivational Syndrome (Option C) â¢ Controversial cannabis-related syndrome â¢ Characterized by unwillingness to persist in tasks requiring prolonged attention â¢ Associated with long-term heavy use â¢ Individuals may become apathetic and anergic Flashbacks â¢ Recurrence of sensations related to cannabis intoxication â¢ Can occur after short-term effects of the substance have disappeared â¢ Not known whether flashbacks are related to cannabis use alone or concomitant use of other substances Reference: Kaplan and Saddock Psychiatry 12th edition, Page 933, 934, 935",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 11,
      "question": "A 28-year-old man presents to his primary care physician with complaints of irritability, anxiety, and difficulty sleeping. He reports having been a daily cannabis user for the past 5 years but stopped abruptly 3 days ago. Which of the following is the most appropriate first-line approach for managing this patient's symptoms?",
      "options": {
        "A": "Prescribe benzodiazepines for anxiety and sleep",
        "B": "Start bupropion for mood stabilization",
        "C": "Provide supportive counseling and psychoeducation",
        "D": "Initiate medically assisted withdrawal with cannabinoid agonists"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Provide supportive counseling and psychoeducation Explanation: Supportive counseling and psychoeducation are the first-line approaches in the management of cannabis withdrawal. This patient is experiencing typical symptoms of cannabis withdrawal, which generally do not require pharmacological intervention as a first step. Cannabis withdrawal Aspect Details Onset and Duration â¢ Typically occurs 24-48 hours after cessation â¢ Most symptoms peak at days 2-6 â¢ Can last up to 3 weeks or more in heavy users Common Symptoms â¢ Irritability â¢ Anxiety â¢ Disturbed sleep/dreaming â¢ Depressed mood â¢ Loss of appetite â¢ Cannabis cravings â¢ Nervousness â¢ Restlessness Less Common Symptoms â¢ Headaches â¢ Physical tension â¢ Sweating â¢ Chills â¢ Stomach pain â¢ Tremors First-line Management â¢ Supportive counseling â¢ Psychoeducation about withdrawal symptoms â¢ Encouraging healthy coping strategies Pharmacological Management â¢ No medications specifically approved for cannabis withdrawal â¢ Symptomatic treatment may be considered (e.g., for anxiety, sleep disturbances) â¢ Some agents (e.g., cannabinoid agonists) used off-label in clinical practice Special Considerations â¢ Inpatient management may be indicated for patients with significant comorbid mental health disorders or polysubstance use â¢ Withdrawal symptoms may precipitate relapse to cannabis use Prescribe benzodiazepines for anxiety and sleep ( Option A): While benzodiazepines might help with anxiety and sleep disturbances, they are not the first-line approach for cannabis withdrawal due to their own addiction potential. Start bupropion for mood stabilization (Option B): Bupropion is not typically used for cannabis withdrawal. It's primarily used for depression and smoking cessation. Initiate medically assisted withdrawal with cannabinoid agonists ( Option D): While cannabinoid agonists have been studied for managing withdrawal symptoms, they are not approved specifically for this purpose and are not considered first-line treatment. Reference: Kaplan and Saddock Psychiatry 12th edition, Page 932, 933 https://pubmed.ncbi.nlm.nih.gov/34791767/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 12,
      "question": "A 20-year-old college student is brought to the emergency department by his roommate. The patient appears disoriented and anxious, with conjunctival injection and tachycardia. His roommate reports that they were experimenting with various forms of cannabis earlier in the evening. Which of the following statements about cannabis use and intoxication is correct? with cannabis use",
      "options": {
        "A": "Oral ingestion of cannabis typically leads to a shorter duration of effects compared to inhalation",
        "B": "Cannabidiol (CBD) is the primary psychoactive component responsible for the \"high\" associated",
        "C": "Cannabinoid receptors are Gq subtype of G-protein coupled receptors",
        "D": "Tachycardia and conjunctival redness are common features of cannabis intoxication"
      },
      "correct_answer": "D",
      "explanation": "intoxication Correct Answer: D) Tachycardia and conjunctival redness are common features of cannabis intoxication Explanation: Tachycardia and conjunctival redness are common clinical features which are seen during cannabis intoxication. Cannabis: Aspect Details Composition â¢ Over 400 compounds â¢ Includes cannabinoids, flavonoids, and terpenoids â¢ Primary psychoactive component: Tetrahydrocannabinol (THC) Forms â¢ Dried plant material (marijuana) â¢ Bhang (Derived from dried leaves) â¢ Ganja (derived from flowering stem) â¢ Hashish (concentrated resin) â¢ Oils and extracts (Hash oil) â¢ Edibles â¢ Topical preparations Receptors CB1 and CB2 (G-protein coupled receptors- Gi subtype ) (Option C) Methods of Use â¢ Smoking (most common) â¢ Vaporizing â¢ Oral ingestion â¢ Sublingual administration â¢ Topical application Clinical Features of Intoxication â¢ Tachycardia â¢ Conjunctival injection â¢ Anxiety or euphoria â¢ Slowness of time â¢ Impaired cognition and motor coordination â¢ Dry mouth â¢ Increased appetite â¢ Nystagmus â¢ Postural hypotension â¢ Delirium (especially at high doses) Onset and Duration of Effects â¢ Smoking: Rapid onset (minutes), duration 2-3 hours â¢ Oral ingestion: Delayed onset (30-90 minutes), duration 4-12 hours Option A: Oral ingestion of cannabis typically leads to a longer duration of effects compared to inhalation. Option B: Tetrahydrocannabinol (THC), not cannabidiol (CBD), is the primary psychoactive component responsible for the \"high\" associated with cannabis use. CBD is non-psychoactive and is being studied for its potential therapeutic effects. Reference: Kaplan & Sadockâs Synopsis of Psychiatry, 12th Edition, Page 930, 931, 940, 941 https://www.ncbi.nlm.nih.gov/books/NBK430801/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 13,
      "question": "A 35-year-old male with opioid use disorder presents with severe muscle aches, diarrhea, abdominal cramps, restlessness, and chills after stopping heroin \"cold turkey.\" He has piloerection, dilated pupils, tachycardia, and mild hypertension. He refuses opioid for managing the withdrawals. What is the most appropriate initial pharmacological treatment for his opioid withdrawal symptoms?",
      "options": {
        "A": "Methadone",
        "B": "Buprenorphine + Naloxone combination therapy",
        "C": "Clonidine",
        "D": "Naloxone"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Clonidine Explanation: Clonidine is an alpha-2 adrenergic agonist that helps reduce the autonomic symptoms of opioid withdrawal, such as sweating, restlessness, tachycardia, and hypertension. It works by decreasing sympathetic outflow, which alleviates symptoms like piloerection, tremors, and rhinorrhea. Clonidine is particularly useful in patients who are unwilling to use opioid-based treatments as in this patient. Methadone (Option A) and Buprenorphine and Naloxone combination therapy (Options B & D) are opioid agonists used for maintenance therapy, but this patient prefers a non-opioid treatment. Opioid withdrawal symptoms include Muscle and Bone aches, Abdominal cramps Diarrhea, Lacrimation, Rhinorrhea, Sweating - resembles flu Piloerection/ Gooseflesh (\"Cold Turkey\" Means Abstinence Syndrome) Frequent yawning , Insomnia Mydriasis Hypertension, Tachycardia Temperature Dysregulation (Hypothermia Or Hyperthermia) Nausea, vomiting, and restlessness Treatment of Opioid Withdrawal Detoxification Maintenance Opioid Agents Methadone: Opioid Agonist. Buprenorphine :Partial Opioid Agonist. Opioid Substitution Therapy (OST): Methadone : Full opioid agonist Improves treatment retention and reduces criminal behavior. 80â120 mg/day. Side effects: constipation, sweating, sexual dysfunction. Buprenorphine : Partial opioid agonist with a ceiling effect (limits overdose risk). Combined with naloxone to prevent abuse. Taken sublingually (tablet/film). Side effects: constipation, nausea, drowsiness. Opioid Antagonists (Naloxone, Naltrexone): Naloxone : Reverses opioid overdose (emergency use). Naltrexone : Blocks opioid effects to prevent euphoria, reduces opioid cravings. Available in oral and long-acting injectable forms. Does not cause dependence or withdrawal but requires patient adherence. Opioid addicted patient but unwilling to be treated with opioids: Symptomatic agents Clonidine Alpha-2 Adrenergic Agonist. Reduces autonomic withdrawal symptoms- Sweating, Restlessness, Tremor or Rhinorrhea. Anxiety: Benzodiazepines Insomnia: Zolpidem Musculoskeletal Pain: NSAIDs ( Ibuprofen ) GI Symptoms: Antiemetic Diarrhea ( Loperamide ) Pregnant Women with Opioid Use Disorder: Illicit opioid use during pregnancy increases risks for both mother and baby Methadone or buprenorphine maintenance reduces risks, though neonatal opioid withdrawal may still occur. Associated risks- Neonatal infections (HIV), premature labor, low birth weight, and sudden infant death syndrome (SIDS). Psychotherapy Modalities/ Non-",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 14,
      "question": "A 30-year-old male is found unresponsive on the floor of his apartment by a friend. Upon arrival, emergency medical personnel observe the following: the patient has a weak pulse, slow and shallow respirations, and pinpoint pupils. His skin is cold and clammy, and there are needle track marks on his arms. His blood pressure is significantly low. What is the most appropriate initial treatment for this patient?",
      "options": {
        "A": "Administer intravenous naloxone at a rapid rate",
        "B": "Ensure an adequate airway and mechanically ventilate the patient",
        "C": "Give intravenous fluids to manage hypotension",
        "D": "Perform a CT scan to rule out intracranial hemorrhage"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Ensure an adequate airway and mechanically ventilate the patient. Explanation: The patient is found unresponsive, exhibiting slow and shallow respirations, hypotension, and pinpoint pupils. The presence of cold, clammy skin and needle track marks on his arms strongly suggests recent drug use. Given these features, the most probable diagnosis is opioid overdose. Ensuring an adequate airway and mechanically ventilating the patient is the correct initial action in opioid overdose cases. Maintaining airway patency, aspiration of secretions, and providing mechanical ventilation are critical to ensure oxygenation until naloxone can be administered. Opioid Toxicity Clinical features Treatment Clinical Triad Opioid overdose often leads to respiratory arrest. Symptoms include marked unresponsiveness, coma, slow respiration, hypothermia, hypotension, and bradycardia Inspect for needle tracks in arms, legs, ankles, groin, and dorsal vein of the penis. Ensure an adequate airway; aspirate secretions if needed. Use mechanical ventilation until naloxone is given. Drug of Choice: Intravenous Naloxone Opioid Antagonist which is a short acting. Given at a slow rate of 0.8 mg/70 kg of body weight. (Option A) Signs of improvement Increase respiratory rate Pupillary Dilation If there is no response after the initial dose, repeat naloxone every few minutes. If no response after 4-5 mg, consider nonopioid substances as factors. Give intravenous fluids to manage hypotension (Option C): While managing hypotension is important, it is not the immediate priority in suspected opioid toxicity. The main focus should be on airway management and ventilation. Perform a CT scan to rule out intracranial hemorrhage (Option D): This is not appropriate in the acute management of suspected opioid overdose. The priority is to stabilize the patientâs airway and breathing rather than imaging, which can be deferred until the patient is stable.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 15,
      "question": "A 28-year-old woman is brought by her family. They report that over the past year, she has been using increasing amounts of opioids, initially prescribed for chronic back pain. The patient admits to using opioids in larger amounts than intended and has made several unsuccessful attempts to cut down. She has given up her hobbies and often misses work due to opioid use. Recently, she was arrested for stealing prescription pads from her doctor's office. Despite these issues, she continues to use opioids daily. Which of the following statements BEST characterizes this patient's condition based on the information provided? absence of physiological symptoms social impairment medically sanctioned",
      "options": {
        "A": "The patient meets criteria for opioid dependence, with evidence of tolerance and withdrawal",
        "B": "The patient exhibits opioid abuse but does not meet the full criteria for dependence due to the",
        "C": "The patient meets the criteria for opioid dependence, with prominent features of impaired control and",
        "D": "The patient's behavior suggests opioid misuse rather than dependence, as the initial use was"
      },
      "correct_answer": "C",
      "explanation": "impaired control and social impairment Correct Answer: C) The patient meets the criteria for opioid dependence, with prominent features of impaired control and social impairment Explanation: The behavioral and clinical features of the patient align with the diagnostic criteria for substance dependence according to DSM-5, as given below: Impaired control: The patient uses opioids in larger amounts than intended and has made unsuccessful attempts to cut down. Social impairment: She has given up hobbies and often misses work due to opioid use. Continued use despite consequences: She continues to use despite legal problems (arrested for stealing prescription pads) and negative impacts on her life. Dependence: Dependence is a state where a person exhibits both physical and psychological symptoms related to substance use. Type of Dependence Definition Behavioral Dependence Focuses on substance-seeking behaviors and the patterns of pathological use. Physical Dependence Refers to the physiological effects that result from repeated episodes of substance use. Psychological Dependence Also called habituation, characterized by a persistent or occasional craving to avoid dysphoria. Substance Use Disorder Criteria (DSM-5) : The criteria for diagnosing substance dependence can be grouped into four main categories: Impaired Control: Using larger amounts or for longer periods than intended Persistent desire or unsuccessful efforts to cut down or control use Spending excessive time obtaining, using, or recovering from the substance Experiencing intense cravings or urges to use the substance Social Impairment: Failing to fulfill major role obligations due to substance use Continuing use despite persistent social or interpersonal problems Giving up important activities because of substance use (Progressive Neglect) Risky Use: Recurrent use in physically hazardous situations Continued use",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 16,
      "question": "A 45-year-old male patient with a history of alcohol use disorder presents for treatment. He has recently been diagnosed with compensated liver failure. The patient expresses a strong desire to quit drinking and is motivated to maintain abstinence. His medical history includes no liver failure, and he is currently not consuming alcohol. Which pharmacological treatment is the most appropriate for this patient to help manage his alcohol cravings?",
      "options": {
        "A": "Disulfiram",
        "B": "Acamprosate",
        "C": "Naltrexone",
        "D": "Ondansetron"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Acamprosate Explanation: Acamprosate is effective for managing alcohol cravings and is safe for use in patients with liver dysfunction. It works as an NMDA receptor antagonist and a positive allosteric modulator of GABA-A receptors, making it suitable for this patient. To maintain the Abstinence, here we have two pillars of maintenance: Pharmacological Treatment Non-Pharmacological Treatment Pharmacological Treatment Deterrent Agent (Aversive Agent) Disulfiram (Alcohol Sensitizing Agent). Irreversible Inhibitor of Aldehyde Dehydrogenase (ALDH) enzyme. This enzyme helps in conversion of acetaldehyde to acetic acid. Patients on Disulfiram treatment consume alcohol. â Alcohol in the body is converted to acetaldehyde but further metabolism is suppressed. â Increased Acetaldehyde levels â Causes Nausea, Vomiting, burning sensation in face or stomach â Severe reaction can lead to heart failure, Ml or respiratory depression â Disulfiram Alcohol Reaction Disulfiram should be used in patients with motivation to abstain from alcohol. Dose of Disulfiram- 250 mg (daily), given with the consent of the patient. Key Points Before Starting Disulfiram to avoid Disulfiram reaction: Wait 12 hours after the last alcohol intake before starting disulfiram. Avoid alcohol for 2 weeks after stopping Disulfiram. Check for alcohol in foods (like vinegar), perfumes, and cough syrups. Monitor liver function tests due to potential risk of hepatitis. (Option A ruled out) Anticraving Agents Both Acamprosate and Naltrexone are FDA approved anti-craving agents for alcohol. Anticraving Agents Acamprosate Naltrexone NMDA Antagonist and positive allosteric modulator of GABA-A receptors. Given after stopping the consumption of alcohol. Contraindicated in severe Renal Impairment. In moderate renal impairment (given in reduced doses). FDA approved. Opioid Antagonist. Can be started when a patient is consuming alcohol or in withdrawal phase. Contraindicated in Liver Failure. (Option C) Check LFTs periodically. FDA approved. Other anti craving Agents are which are not FDA approved but effective: Ondansetron (5HT-3 Antagonist) (Option D) Topiramate (Anti Epileptic agent) Baclofen (GABA-B Agonist) Fluoxetine (SSRI) Non- Pharmacological Treatment Counseling in the first 3 to 6 months. Both individual and group counseling are effective. Initially, counseling should occur at least three times a week for the first 2 to 4 weeks, followed by",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 17,
      "question": "A 45-year-old man with a history of alcohol use disorder presents after abrupt cessation of drinking. He shows anxiety, tremors, and experiences a seizure. Which medication would be most appropriate for managing his withdrawal symptoms?",
      "options": {
        "A": "Haloperidol",
        "B": "Carbamazepine",
        "C": "Thiamine",
        "D": "Lorazepam"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Lorazepam Explanation: Benzodiazepines (such as Lorazepam) are the drug of choice for managing alcohol withdrawal symptoms. Alcohol withdrawal Seizures: Seizures can occur suddenly; about 1% may experience a single grand mal convulsion, typically on the second day of withdrawal. Treatment of choice: Benzodiazepines. Anticonvulsants are not more beneficial. Detoxification: Withdrawal Treatment Mild or Moderate Withdrawal Treatment: Benzodiazepines (e.g., lorazepam, chlordiazepoxide, diazepam) . Short-acting (e.g., lorazepam) or long-acting (e.g., chlordiazepoxide, diazepam). Carbamazepine (daily doses of 800 mg) is also effective and has minimal abuse liability. Severe withdrawal (Seizures) Treatment of choice: Benzodiazepines Anticonvulsants are not more beneficial. Life threatening (Delirium Tremens) For extreme symptoms (delirium tremens or DTs): Higher doses of Benzodiazepines (e.g., 50-100 mg chlordiazepoxide every 4 hours or lorazepam IV). Supportive care: High-calorie diet, multivitamins. Haloperidol may be used for severe agitation but can lower seizure threshold. Protracted Withdrawal: Symptoms may last 2 to 6 months. Acamprosate may help diminish some symptoms. Cognitive and behavioral approaches recommended. Treatment of withdrawal in Liver Disease: Lorazepam, Oxazepam, and Temazepam (LOT) Treatment of Alcohol Withdrawal-Related Hallucinations: Similar to DTs: Benzodiazepines , adequate nutrition, and fluids. If necessary, add antipsychotics (haloperidol) for long-term cases. Treatment of Alcohol-Induced Amnestic Disorders: Wernicke Encephalopathy Treatment: Thiamine 100 mg by mouth 2-3 times daily for 1-2 weeks. If receiving IV glucose, add 100 mg thiamine per liter. Korsakoff Syndrome Treatment: Thiamine 100 mg by mouth 2-3 times daily for 3-12 months. Full recovery is rare; many experience cognitive improvement with thiamine and nutritional support. Alcoholic Pellagra Encephalopathy For patients unresponsive to thiamine: Niacin 50 mg by mouth four times daily or 25 mg parenterally 2-3 times daily. Treatment of Idiosyncratic Alcohol Intoxication: Protect patients from harm; physical restraint may be required. Consider using Haloperidol to control assaultiveness. Differentiate from other behavioral changes (e.g., complex partial epilepsy). Haloperidol (Option A) is used for severe agitation and hallucinations; it does not address withdrawal symptoms or prevent seizures effectively. Thiamine (Option C) is essential for preventing Wernicke encephalopathy, but does not directly manage acute withdrawal symptoms. Carbamazepine (Option B) is also effective in managing withdrawals, but benzodiazepines are the drug of choice.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 18,
      "question": "A 50-year-old man comes to the clinic for a routine evaluation after his friends expressed concern about his drinking habits. He reports consuming alcohol heavily for several years. The physician orders laboratory tests to assess his alcohol intake. Which test result is most indicative of his heavy alcohol consumption? C. Î³ -glutamyltransferase",
      "options": {
        "A": "Mean corpuscular volume",
        "B": "Alanine aminotransferase",
        "D": "Carbohydrate-deficient transferrin"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Carbohydrate-deficient transferrin Explanation: A Carbohydrate-deficient transferrin (CDT) level above 3.0% is a well-established and specific biomarker for heavy alcohol intake. It reflects chronic alcohol consumption and is less affected by other conditions compared to the other tests. Laboratory tests in Alcoholism Î³ -glutamyltransferase ( GGT ) >35.0 U/L Chronic alcohol abuse Elevated GGT levels indicate liver disease and are often found in chronic heavy drinkers, but only 30â50% of excessive drinkers show elevated levels (Option C) . Not specific to alcohol use, as other conditions like pancreatitis and prostate disease can also raise its levels. Carbohydrate-deficient transferrin ( CDT ) >3.0% Most important biomarker for heavy alcohol intake. (Option D) Good sensitivity and specificity. Mean corpuscular volume ( MCV ) >91.0 Âµ m3 Heavy alcohol use MCV levels can remain elevated for several months after someone stops drinking, meaning a person may be abstinent yet still have a high MCV value. (Option A) Serum glutamic pyruvic transaminase (alanine aminotransferase)- ALT >45.0 IU/L Chronic alcohol abuse More specific marker of alcohol-induced liver injury since it is mainly located in the liver. (Option B) Serum glutamic oxaloacetic transaminase (aspartate aminotransferase)- AST >45.0 IU/L Chronic alcohol abuse The AST to ALT ratio helps confirm heavy alcohol consumption. (Ratio >2 is correlated with alcoholic liver disease) N-Acetyl- Î² -Hexosaminidase ( Beta-Hex ) Increased beta-Hex subsides to normal levels after only 7 to 10 days of abstinence. Diabetes and hypertension also elevate beta-Hex. Assessment tools for Alcohol use disorders: CAGE Questionnaire (Need to) C ut down on Drinking. A nnoyance when asked about your drinking. G uilty about your drinking. E ye openers after drinking first thing in the morning to steady your nerves or get rid of a hangover the morning after heavy drinking. Positive response on 2 or more is suggestive of Alcohol Use Disorders. AUDIT - Alcohol Use Disorder Identification Test MAST - Michigan Alcoholism Screening Test SADQ: Severity of Alcohol Dependence Questionnaire (used to assess severity of dependence). Reference: Kaplan & Sadockâs Synopsis of Psychiatry, 12th Edition, Page 902, 903 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601655/ https://americanaddictioncenters.org/alcohol/assessment",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 19,
      "question": "A 45-year-old man visits a sleep specialist due to persistent insomnia. He mentions that he often drinks alcohol in the evenings, believing it helps him sleep better. After discussing his sleep patterns, the specialist explains that alcohol has several effects on sleep quality and architecture. Which of the following is not an effect of alcohol on sleep?",
      "options": {
        "A": "Decreases sleep latency",
        "B": "Increases REM sleep",
        "C": "Increases sleep fragmentation",
        "D": "Decreased deep sleep due to its sedative properties"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Increases REM sleep Explanation: While alcohol may initially help decrease sleep latency, it actually disrupts overall sleep quality. Specifically, alcohol does not increase REM sleep ; rather, it decreases REM and deep sleep , leading to more fragmented sleep. Effects of Alcohol on Sleep While evening alcohol consumption may make it easier to fall asleep and reduce sleep latency, this effect is largely attributable to its sedative properties. (Option A) Alcohol has adverse effects on the sleep architecture: Decrease in REM Sleep and decrease in deep sleep. (Option D) More sleep fragmentations with more and longer episodes of awakening at night. (Option C) Chronic use of alcohol leads to tolerance, requiring higher amounts or more frequent dosing to achieve the same sedative effects. Rebound Insomnia: Upon withdrawal or after developing tolerance, individuals may experience rebound insomnia, which can be more severe than the original sleep disturbance. Idea that drinking improves sleep is a myth. While it may facilitate initial sleep onset, it ultimately disrupts overall sleep quality. Reference: Kaplan & Sadockâs Synopsis of Psychiatry, 12th Edition, Page 924, 1566",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 20,
      "question": "A 55-year-old man with a history of chronic alcohol use presents to the emergency with sudden onset loss of consciousness and seizures. He also shows signs of confusion, apathy, dementia, visual hallucinations and aggressive behavior. An MRI is performed, revealing the findings shown below. What is the most likely diagnosis?",
      "options": {},
      "correct_answer": "",
      "explanation": "",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 21,
      "question": "A 45-year-old man with a history of chronic alcohol use is referred to a psychiatrist after he exhibits significant memory impairment, particularly anterograde amnesia, and frequently confabulates to fill memory gaps. After initial stabilization, what is the most appropriate next step in the management of this patient?",
      "options": {
        "A": "Increase thiamine dosage to 1g daily",
        "B": "Initiate treatment with Niacin",
        "C": "Initiate thiamine supplementation at 100 mg, 2-3 times/day",
        "D": "Start cognitive rehabilitation therapy"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Initiate thiamine supplementation at 100 mg, 2-3 times/day Explanation: The patientâs memory impairment and confabulation, following chronic alcohol use, indicate a diagnosis of Korsakoff syndrome. This condition results from thiamine deficiency, which is common in individuals with prolonged alcohol consumption. Continuing thiamine supplementation at 100 mg, 2-3 times/day is essential for addressing the underlying deficiency. This treatment helps mitigate cognitive decline and supports recovery from memory impairment. Korsakoff syndrome Onset Chronic progression of Wernicke Encephalopathy Symptoms Impaired recent memory Anterograde amnesia: More common, inability to form new memories. Retrograde amnesia: Inability to recall old memories. Confabulation: Making false stories to fill memory gaps. These are unintentional. Cause Thiamine (Vitamin B1) deficiency Neuropathologic Lesions Symmetrical involvement of: Mammillary bodies Thalamus, Hypothalamus Midbrain Pons Medulla Cerebrum Treatment Supplementation of Thiamine 100 mg, 2-3 times/day for 3-12 months. Full recovery is only seen in 20% of patients, others see partial improvement and symptoms may not completely resolve. If patients do not respond to Thiamine: Consider Alcohol Pellagra Encephalopathy and treat with Niacin . (Option B) Increasing thiamine dosage to 1g daily (Option A) is not standard practice and may not offer additional benefits compared to established dosing guidelines. Start cognitive rehabilitation therapy (Option D): While cognitive rehabilitation therapy can be beneficial, it should be introduced after ensuring consistent thiamine supplementation, which is essential for the patient's recovery. Reference: Kaplan & Sadockâs Synopsis of Psychiatry, 12th Edition, Page 895, 919",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 22,
      "question": "A 45-year-old man with a history of chronic alcoholism is brought to the emergency department by his family. They report that he has been confused and unsteady on his feet for the past two days. On examination, the patient is disoriented and has difficulty maintaining his balance. You also notice bilateral nystagmus and weakness in his lateral eye movements. Which of the following is the most appropriate immediate treatment?",
      "options": {
        "A": "Intravenous Glucose",
        "B": "Intravenous thiamine",
        "C": "Benzodiazepines",
        "D": "Haloperidol"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Intravenous thiamine Explanation: The patient's symptoms are consistent with Wernicke's encephalopathy, which requires immediate treatment with thiamine to prevent progression to Korsakoff syndrome. Wernicke's encephalopathy is an acute neurological emergency caused by thiamine (vitamin B1) deficiency, often seen in chronic alcoholics due to poor nutrition and impaired thiamine absorption. In this case, the patient presents with the classic triad of Wernicke's encephalopathy: G lobal Confusion O cular abnormalities (nystagmus, weakness in lateral eye movements) A taxia (unsteady on his feet) Immediate treatment with intravenous thiamine is crucial to prevent progression to the chronic, often irreversible Korsakoff syndrome. Feature Wernicke's Encephalopathy Korsakoff Syndrome Onset Acute Chronic, often follows Wernicke's Key Symptoms â¢ Global Confusion â¢ Ocular abnormalities (nystagmus, gaze palsy) â¢ Ataxia (especially gait) â¢ Severe anterograde amnesia â¢ Retrograde amnesia â¢ Confabulation (in some cases) Cause Thiamine deficiency Prolonged thiamine deficiency Neuropathological lesions Symmetrical and paraventricular, involving mammillary bodies, thalamus, hypothalamus,midbrain, pons, medulla, fornix, and cerebellum Treatment Immediate IV thiamine Long-term thiamine supplementation, supportive care Prognosis Potentially reversible with prompt treatment Often irreversible, only about 20% recover NOTE: In patients with alcohol-related disorders who are receiving IV glucose solution, it is good practice to include 100 mg of thiamine in each liter of the glucose solution . In a patient who appears to have WernickeâKorsakoff syndrome but who does not respond to thiamine treatment , one should consider the diagnosis of alcoholic pellagra encephalopathy due to niacin (nicotinic acid) deficiency . Treatment: 50 mg of niacin by mouth four times daily or 25 mg parenterally two to three times daily. Reference: Kaplan and Saddock Psychiatry. 12th edition, Pages 895, 896",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 23,
      "question": "A 50-year-old man with a 20-year history of daily alcohol use is admitted to the hospital for pneumonia. Two days after admission, he becomes agitated and reports seeing insects crawling on the walls. His vital signs show tachycardia (HR 110 bpm), hypertension (BP 160/95 mmHg), and a fever of 38.2Â°C (100.8Â°F). He is disoriented and tremulous. Which of the following is the most accurate statement about this patient's condition?",
      "options": {
        "A": "He is experiencing early symptoms of alcohol withdrawal",
        "B": "He is likely developing Wernicke's encephalopathy",
        "C": "He is showing signs of delirium tremens",
        "D": "His symptoms are typical of impending alcohol withdrawal seizures"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) He is showing signs of delirium tremens Explanation: The patient's symptoms and their timing are consistent with delirium tremens (DTs), which is the most severe form of alcohol withdrawal. Alcohol Withdrawal- Clinical features Stage Symptoms Onset after last drink Mild withdrawal â¢ Mild anxiety â¢ Tremulousness â¢ Nausea â¢ Headache â¢ Palpitations 6-8 hours Moderate (Alcoholic hallucinosis) â¢ Visual, auditory, or tactile hallucinations â¢ Intact orientation â¢ Normal vital signs 8- 12 hours Severe (Withdrawal seizures) â¢ Generalized tonic-clonic seizures â¢ Usually brief and self-limited â¢ Also known as rum fits 12-24 hours Life threatening (Delirium tremens) â¢ Severe agitation â¢ Confusion and disorientation â¢ Hallucinations (often visual) â¢ Autonomic hyperactivity (tachycardia, hypertension, fever) â¢ Profound sweating â¢ Tremors â¢ Insomnia Within 72 hours Option A: Early symptoms of alcohol withdrawal is incorrect because the patient's symptoms are more severe and occur later than early withdrawal symptoms. Option B: Wernicke's encephalopathy is not a component of alcohol withdrawal and while it can cause confusion, it typically also presents with ataxia and ocular changes, which are not mentioned in this case. Option D: Alcohol withdrawal seizures are a serious complication of alcohol withdrawal, they typically occur earlier and do not account for the other symptoms described. Reference: Kaplan & Sadockâs Synopsis of Psychiatry, 12th Edition, Page 890, 891, 892, 893",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 24,
      "question": "A 25-year-old man is brought to the emergency department after being found unconscious at a party. His friends report that he consumed a large amount of alcohol over a short period. On examination, the patient is unresponsive to verbal stimuli, has irregular breathing, and a heart rate of 50 beats per minute. Which range of blood alcohol concentration (in mg/dL) is most likely associated with this patient's condition?",
      "options": {
        "A": "20-30 mg/dL",
        "B": "30-80 mg/dL",
        "C": "80-200 mg/dL",
        "D": ">300 mg/dL"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) >300 mg/dL Explanation: The patient's symptoms are consistent with severe alcohol intoxication, which occurs at blood alcohol concentrations above 300 mg/dL . At this level, impaired vital signs and possible death can occur, as evidenced by the patient's unresponsiveness, irregular breathing, and low heart rate. Principle: Blood alcohol concentration is measured using a breathalyzer which is based on the principle that concentration of alcohol is strongly correlated with concentration of alcohol in arterial blood. Levels of Impairment at Different Blood Alcohol Concentrations BAC (mg/dL) Effects 20-30 (Option A) Slowed motor performance and decreased thinking ability 30-80 (Option B) Increase in motor and cognitive problems 80-200 (Option C) Increase in incoordination and judgment errors, mood lability, deterioration in cognition 200-300 Nystagmus, marked slurring of speech, and alcoholic blackouts >300 Impaired vital signs and possible death Reference: Kaplan and Saddock Psychiatry. 12th edition, Page 889, 890",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 25,
      "question": "Which of the following statements about alcohol absorption and metabolism is correct?",
      "options": {
        "A": "The majority of alcohol absorption occurs in the stomach",
        "B": "Peak Blood Alcohol Concentration (BAC) is typically reached within 5-10 minutes",
        "C": "Consuming alcohol with food accelerates its absorption",
        "D": "Only less than 10% is excreted unchanged in breath, sweat, and urine"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Only less than 10% is excreted unchanged in breath, sweat, and urine breath, sweat, and urine . Ethanol- Pharmacokinetics Aspect Details Absorption 20% absorbed through stomach 80% absorbed through small intestine (Option A) Faster absorption on empty stomach, slower absorption if consumed after food intake (Option C) Distribution Distributed throughout water-containing portions of body Affects organs with high water content (e.g. liver, brain) Metabolism Primary site is liver Enzyme alcohol dehydrogenase converts alcohol to acetaldehyde Further, acetaldehyde is converted into acetate by enzyme aldehyde dehydrogenase <10% excreted unchanged in breath, sweat, and urine Remaining ~90% metabolized by liver Factors Affecting Kinetics Food in stomach (slows absorption) Body weight and composition Gender (females generally reach higher BAC) Genetics (e.g. ADH enzyme variants) Tolerance in chronic drinkers Blood Alcohol Curve Sharp rise during absorption phase Peak at 45-90 minutes after drinking (Option B) Slow decline during distribution phase Faster decline during elimination phase Mellanby effect- more intoxicating effects when BAC is increasing than for the same BAC when decreasing Reference: Kaplan & Sadockâs Synopsis of Psychiatry, 12th Edition, Page 921, 922, 923 https://pubmed.ncbi.nlm.nih.gov/28277803/ https://www.ncbi.nlm.nih.gov/books/NBK20360/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 26,
      "question": "A 35-year-old man is brought to the emergency department after heavy alcohol consumption. His blood alcohol concentration (BAC) was recorded at two different times: once when it was rising to 100 mg/dL and later when it was falling to the same level. The physician noted that the patient appeared more intoxicated during the rising phase of BAC compared to the falling phase, even though the BAC was identical at both points. Which of the following best explains this phenomenon?",
      "options": {
        "A": "Alcohol-Mellanby effect",
        "B": "Reverse tolerance",
        "C": "Acute tolerance",
        "D": "Delirium tremens"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Alcohol-Mellanby effect Explanation: Alcohol-Mellanby effect: This effect describes the observation that individuals tend to experience more pronounced intoxication when their blood alcohol concentration (BAC) is rising compared to when it is falling, even when the BAC is at the same level. This occurs because the brain's sensitivity to alcohol is higher during the absorption phase (when BAC is increasing) than during the elimination phase (when BAC is decreasing). Reverse tolerance (Option B): Reverse tolerance refers to the phenomenon where, over time, smaller amounts of alcohol produce the same or heightened effects, usually due to impaired liver function or changes in brain chemistry. Acute tolerance (Option C): Refers to a reduction in the effects of alcohol within a single drinking session, as the brain quickly adapts to alcohol's presence. Delirium tremens (Option D): It is a severe withdrawal syndrome that occurs after sudden cessation of chronic alcohol consumption. It is characterized by confusion, agitation, hallucinations, and autonomic hyperactivity. This patient's presentation of varying intoxication during rising vs. falling BAC is unrelated to alcohol withdrawal. Reference: Kaplan & Sadockâs Synopsis of Psychiatry, 12th Edition, Effects of Alcohol - Absorption Page 923",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpsychiatry/Disorders-Substance_Use_And_Addictive_Disorders_Q26_exp.jpg",
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 27,
      "question": "A 28-year-old male presents with a long-standing history of cocaine abuse. Which of the following best explains the etiology and maintenance of his substance use disorder?",
      "options": {
        "A": "Genetic polymorphisms affecting dopamine production",
        "B": "Alexithymia leading to self-medication with cocaine",
        "C": "Conditioned learning and neuroplasticity in the brain-reward circuitry",
        "D": "Modulation of the GABA system resulting in tolerance"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Conditioned learning and neuroplasticity in the brain-reward circuitry both psychological and biological aspects. Repeated drug use leads to conditioned responses to drug-related stimuli and causes changes in the brain's reward system, particularly in the dopaminergic pathways from the ventral tegmental area to the nucleus accumbens. This process explains both the development and maintenance of the disorder. Etiology of Substance Use Disorders: Substance use disorders (SUDs) have a multifaceted etiology involving biological, psychological, and environmental factors. Biological Factors Genetic Predisposition Studies of twins, adoptees, and siblings indicate a strong genetic component, particularly in alcohol use disorders. Genetic factors may influence neurotransmitter systems, affecting an individual's response to substances. Neurochemical Changes SUDs involve alterations in brain neurotransmitter systems, particularly: Dopaminergic system: Critical in the brain's reward circuitry Opioid system: Involved in pain modulation and reward GABA system: Implicated in anxiety reduction and sedation The ventral tegmental area (VTA) and its projections to the nucleus accumbens are key in the brain-reward circuitry. Neuroplasticity Repeated substance use leads to adaptive changes in the brain, affecting: Neurotransmitter release Receptor function Second-messenger systems Gene regulation Psycho- logical Factors Learning and Conditioning Operant conditioning: Substance use is reinforced by its consequences (e.g., euphoria, relief from negative states). Classical conditioning: Environmental cues associated with substance use can trigger craving or withdrawal symptoms. Cognitive Factors Beliefs about substance effects Expectations of drug-related outcomes Impaired decision-making processes Mental Health Pre-existing mental health issues may contribute to substance use as a form of self-medication. Some individuals may have difficulty recognizing or expressing emotions (alexithymia) , potentially leading to substance use. Environmental/ Social Factors Social Peer pressure and social norms Family dynamics and modeling of substance use behavior Cultural attitudes towards substance use Availability and Accessibility Ease of obtaining substances Exposure to drug-using environments Stress and Life Events Chronic stress or traumatic experiences may increase vulnerability to substance use. Interplay of Factors Initial use may be influenced by environmental factors (e.g., availability, peer pressure). Continued use is affected by individual biology and psychology (e.g., how drug effects are perceived, and the development of tolerance). Progression to dependence involves neuroadaptive changes, learning processes, and environmental reinforcement. Genetic polymorphisms affecting dopamine production (Option A) : While",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    },
    {
      "q_no": 28,
      "question": "A 25-year-old man presents to the emergency room after consuming a large quantity of alcohol during a party. He mentions that this was the first time he drank so much, and he was urged by friends to continue drinking. He has no history of alcohol use before this event, and he assures that he does not intend to consume alcohol regularly. His physical exam reveals elevated blood pressure, nausea, and mild confusion. His liver function tests are slightly elevated. What is the most appropriate diagnosis?",
      "options": {
        "A": "Alcohol dependence",
        "B": "Alcohol withdrawal",
        "C": "Single episode of harmful use",
        "D": "Delirium tremens"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Single episode of harmful use Explanation: Single Episode of Harmful Substance Use (ICD-11) Diagnosed after an episode where physical or mental health damage occurs, affecting the user or others. Allows for early intervention and prevention of further harm. ICD-11 Highlight: Explicitly includes harm to others' health. Refers to acute effects and may include substance-induced psychological disorders but excludes harm from established patterns of harmful use. In this case, the patient consumed a large amount of alcohol during one event, resulting in harmful effects such as nausea, elevated blood pressure, and mild confusion. There is no history of regular alcohol use, and the patient does not exhibit any signs of dependence or withdrawal. This makes the diagnosis of a single episode of harmful use appropriate. Alcohol dependence (Option A) : Involves a pattern of chronic alcohol use characterized by tolerance, withdrawal symptoms, and an inability to control drinking. This patient does not show these features, and this was a single, isolated event. Alcohol withdrawal (Option B) : Occurs in individuals who stop or reduce heavy, chronic alcohol use, leading to symptoms such as tremors, anxiety, and seizures. This patient does not have a history of chronic alcohol use, nor is there evidence of withdrawal symptoms. Delirium tremens (Option D) : It is a severe form of alcohol withdrawal characterized by confusion, agitation, and hallucinations. It occurs in individuals with long-term alcohol dependence who abruptly stop drinking. Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881115/#:~:text=Episode%20of%20Harmful%20Psyc hoactive%20Substance%20Use%20Inclusion,of%20use%20(World%20Health%20Organization%2C%202019)",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Disorders-Substance Use And Addictive Disorders"
    }
  ]
}
